| Alteration of the OCT2 locus does not correlate with its suppressed expression in Hodgkin lymphoma. | Alterations of loci encoding PU.1, BOB1, and OCT2 transcription regulators do not correlate with their suppressed expression in Hodgkin lymphoma.
Cavazzini F, De Wolf-Peeters C, Wlodarska I. | 01/21/2010 |
| physical binding to the family of repeats in Epstein-Barr virus oriP by the cellular transcription factors Oct-1 and Oct-2 was demonstrated by using an electrophoretic mobility-shift assay | Functional interaction of Oct transcription factors with the family of repeats in Epstein-Barr virus oriP.
Almqvist J, Zou J, Linderson Y, Borestrom C, Altiok E, Zetterberg H, Rymo L, Pettersson S, Ernberg I. | 01/21/2010 |
| The function of human Oct-2 in immunoglobulin(Ig)-secreting cells requires plasmacytoma-specific coativator OCA-B working synergistically to sustain the gene expression profile of the Ig-secreting cell. | Critical role for the Oct-2/OCA-B partnership in Ig-secreting cells.
Salas M, Eckhardt LA. | 01/21/2010 |
| Oct-2, therefore, acts as a cell survival factor in t(14;18) lymphoma cells by directly activating the antiapoptotic gene bcl-2. | Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
Heckman CA, Duan H, Garcia PB, Boxer LM. | 01/21/2010 |
| DNase I-hypersensitive site 4 (hs4) enhancer activity in mature Burkitt's lymphoma B cells is regulated by synergistic involvement of both Oct-2 and NF-kappa B family members; Oct-2 is required for hs4 enhancer activity. | NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
Sepulveda MA, Emelyanov AV, Birshtein BK. | 01/21/2010 |
| The transcription factors Oct-1 and -2 inhibit and enhance, respectively, the expression of exon 1-containing transcripts and CCR5 surface levels. | Production of specific mRNA transcripts, usage of an alternate promoter, and octamer-binding transcription factors influence the surface expression levels of the HIV coreceptor CCR5 on primary T cells.
Mummidi S, Adams LM, VanCompernolle SE, Kalkonde M, Camargo JF, Kulkarni H, Bellinger AS, Bonello G, Tagoh H, Ahuja SS, Unutmaz D, Ahuja SK. | 01/21/2010 |